Toggle Offcanvas
...
 
Goserelin Tenders

Goserelin Tenders

View Goserelin tenders, RFPs and contracts. Bid on readily available Goserelin tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Goserelin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Goserelin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Goserelin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Goserelin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

14 Live Notices for Goserelin Tenders

Showing 1 to 14

Purchase Of Chemical Medications, Jets, Dressing Supplies And Materials
country Azerbaijan
posting date06 Mar 2025
deadline29 Apr 2025
Open House Drug Discount Agreements Goserelin, Atc L02Ae03
country Germany
posting date18 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Goserelin (Atc Code: L02Ae03).
country Germany
posting date14 Sep 2024
deadline27 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Goserelin (Atc Code: L02Ae03).
country Germany
posting date14 Sep 2024
deadline27 Aug 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Goserelin (L02Ae03) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date13 Jun 2024
deadline31 May 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Goserelin (L02Ae03) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date13 Jun 2024
deadline31 May 2026
Open House Contracts For Several Active Ingredients/Combinations Of Active Ingredients
country Germany
posting date08 Apr 2024
deadline01 Apr 2026
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Goserelin, Atc L02Ae03 For The Period June 1St, 2023 - May 31St, 2025
country Germany
posting date22 Apr 2023
deadline05 Apr 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Goserelin, Atc L02Ae03 For The Period June 1St, 2023 - May 31St, 2025
country Germany
posting date21 Apr 2023
deadline05 Apr 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Goserelin, Atc L02Ae03 For The Period June 1St, 2023 - May 31St, 2025
country Germany
posting date21 Apr 2023
deadline05 Apr 2025
Docetaxel, Concentrate, 20 Mg/Ml, 4 Ml Each (Docetaxel) (33652100-6); Docetaxel, Concentrate, 20 Mg/Ml, 7 Ml Each (Docetaxel) (33652100-6); Capecitabine Film-Coated Tablets 500 Mg (Capecitabine) (33652100-6); Oxaliplatin, Concentrate (Solution), 5 Mg/Ml, 20 Ml Each (Oxaliplatin) (33652100-6); Epirubicin, Solution (Concentrate), 2 Mg/Ml, 25 Ml Each (Epirubicin) (33652100-6); Goserelin, 10.8 Mg, Syringe Applicator (Goserelin) (33652100-6); Irinotecan, Concentrate, 20 Mg/Ml, 5 Ml (Irinotecan) (33652100-6); Zoledronic Acid, Concentrate For Solution For Infusion, 4 Mg/5 Ml (0.8 Mg/Ml), 5 Ml (Zoledronic Acid) (33632000-9); Calcium Folinate, Solution For Injection, 10 Mg/Ml, 20 Ml (Calcium Folinate) (33690000-3) (Dk 021: 2015: 33600000-6 Pharmaceutical Products)
country Ukraine
posting date11 Feb 2025
deadline11 Feb 2026
Inj. Goserelin Acetate 10.8 (Brand-Zoladex 10.8Mg)
country India
posting date13 Mar 2025
deadline24 Mar 2025
Tab Netupitant Plus Paloanosetrone , Carboplatin450Mg Inj , Pegylated Liposomal Doxorubicin 20Mg Inj ,Goserelin 3 Point 6 Mg Prefilled Syringe , Pegylated Gcsf 6Mg Inj , Buprenorphine Patch 10 Mcg , Cetuximab 100 Mginj , Denosumab 120 Mg Inj , Syp Mycophenolate Mofetil 1G Oblique 5Ml Powder For Oral Suspension , Voriconazole200 Mg Inj , Isoflurane Bottle Of 100 Ml , Cisatracurium 2Mg Oblique Ml Inj Comma 10 Ml Vial , Rocuronium 10 Mgoblique Ml Comma 10 Ml Vial Inj , Paracetamol 1000 Mgcomma 100 Ml Inj , Inj Remifentanil Hcl 2 Mg Powderedform , 1 Comma 6 Dihydroxy 2 To 5 Dioxahexanegluteraldeyde Benzylalkonium Chl Comma Alkyl Ureaderivative 11 Point 2Gm Oblique 5 Point 0Gm 5 Gmoblique3Gm In 100 Gm , 0 Pnt 5Prcent Oblq Chlorhexidineglunate In70 Precent Obliq Ethyl Alcohl With Mosrizer 500Ml Bott With Dispesr Quantity: 61263
country India
posting date12 Mar 2025
deadline01 Apr 2025
(Ph No.:25041) Goserelin 10.8 Mg Inj
country India
posting date10 Mar 2025
deadline20 Mar 2025

Share Share this page